Here are relevant reports on : anti-obesity-drugs-market
-
Epigenetic Drugs & Diagnostics Market - Global Forecast to 2030
Epigenetic Drugs & Diagnostics Market
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Thrombosis Drugs Market by Type, Product, End-Use Industry and Region - Global Forecast to 2033
Thrombosis drugs refer to medications that are used to prevent or treat blood clots that form inside blood vessels, which can lead to serious medical conditions such as heart attack, stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE). These drugs work by either preventing the formation of clots (anticoagulants) or dissolving existing clots (thrombolytics). The market for thrombosis drugs includes both prescription and over-the-counter medications.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Cloud Endpoint Protection Market by Component, Solution (Antivirus, Anti-spyware, Firewall, Endpoint Device Control, Anti-phishing, Endpoint Application Control), Service, Organization Size, Vertical, and Region - Global Forecast 2023
The global cloud endpoint protection market is expected to grow from USD 1,014.4 million in 2018 to USD 1,819.0 million by 2023, at a Compound Annual Growth Rate (CAGR) of 12.4% during the forecast period. Cloud endpoint protection solutions are easy to use SaaS-based security solutions that protect and manage mobile devices and servers from a single console. The advancement in technologies and hacking methods has increased the need for endpoint security system that can learn quickly and defend against security threats in real time. Moreover, benefits such as cost-effectiveness and scalability have propelled the demand for cloud endpoint protection solutions across verticals.
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
India Missile Market by Type (Cruise, Ballistic, Interceptors, Anti-Tank, Anti-Ship, Submarine Launched Missiles), Component (Airframe, Guidance, Navigation, Control, Propulsion, Warhead, Battery), Speed, End User - Forecast To 2030
The major players in the global India Missile Market
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Skin Health Foods Market by Indication (Skin Conditions, Anti-Aging, Anti-Allergy), Region (North America, Europe, Asia Pacific, Rest of the World), Regulatory Landscape, Pricing Analysis - Global Forecast to 2026
The global skin health foods market growth is primed to transition from $1,929.5 million in 2021 to $2,651.5 million by 2026, showcasing a strong CAGR of 6.6%. The growth of this market is mainly driven by the high incidence of allergic diseases, the growth in health awareness among consumers, increasing R&D and production capacity for functional food and beverage products, and the increasing consumption of nutrient-enriched foods to improve overall health.
- Published: July 2022
- Price: $ 4950
- TOC Available:
-
Asia-Pacific (APAC) Missile Market by (Cruise, Ballistic, Interceptors, Anti-Tank, Anti-Ship, Submarine Launched Missiles), Component (Airframe, Guidance, Navigation, Control, Propulsion, Warhead, Battery), Speed, End User - Regional Forecast to 2030
The Asia-Pacific (APAC) missile market is expected to grow from USD 3.69 billion in 2025 to USD 6.26 billion by 2030, at a compound annual growth rate (CAGR) of 11.1% during the forecast period. The key Players RTX Corporation (US), Mitsubishi Heavy Industries Ltd. (Japan), LIG Nex1 (South Korea), MBDA (France), Bharat Dynamics Limited (India), Lockheed Martin (US), Northrop Grumman (US), Elbit Systems Ltd. (Israel), KONGSBERG (Norway), and Rafael Advanced Defense Systems (Israel).
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Digital Therapeutics Market / DTx Market by Offerings (Platform, Virtual Reality/Games), Revenue Model (Subscription, Value Based), Application (Therapy (Diabetes, Obesity, CNS, Respiratory, CVD), Drug Adherence, Rehab/Patient care) - Global Forecast to 2028
The global digital therapeutics market, valued at US$4.4 billion in 2022, stood at US$6.1 billion in 2023 and is projected to advance at a resilient CAGR of 29.1% from 2023 to 2028, culminating in a forecasted valuation of US$21.9 billion by the end of the period. The rapid adoption of digital therapeutics is driven by the rising incidence of chronic diseases, surging investments from venture capital firms, and strategic partnerships between tech companies and healthcare providers.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Patient Engagement Solutions Market by Therapy (CVD, Diabetes, Obesity, Fitness), Functionality (Telehealth, E-Prescribing, Scheduling, Billing), End User (Hospital, Payer, Patient), Unmet Need, Investment, Market Share, Trends - Global Forecast to 2030
The global patient engagement solutions market, valued at USD 25.79 billion in 2024, stood at USD 29.33 billion in 2025 and is projected to advance at a resilient CAGR of 12.0% from 2025 to 2030, culminating in a forecasted valuation of USD 51.69 billion by the end of the period. The patient engagement solutions market is driven by the growing shift toward patient-centric care, rising adoption of digital health technologies, increasing prevalence of chronic diseases, and the expanding use of mobile apps, portals, and remote monitoring tools to support continuous patient interaction
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
North America Weight Loss /Obesity Management Market – [Meal Replacements, Slimming Centers, Nutrition & Psychological Consultancy, Treadmill, Ellipticals, Strength Training, Gastric Bypass, Intragastric Balloon System, StomaphyX] – Forecasts to 2017
Obesity and weight gain have always been major concerns regarding the health and fitness of individuals; today, it has reached the level of an epidemic. Increasing obesity rate and increasing levels of awareness amongst calorie-conscious consumers in North America have opened new avenues for the weight management industry.
- Published: July 2013
- Price: $ 4950
- TOC Available:
-
Biosimilars Market by Drug Class (mAbs (Adalimumab, Infliximab, Rituximab, Trastuzumab), GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1), Indication (Oncology, Autoimmune, Diabetes, Obesity), Competitive Landscape, Region - Global Forecast to 2035
The global biosimilars market, valued at US$32.75 billion in 2024, stood at US$35.04 billion in 2025 and is projected to advance at a resilient CAGR of 7.5% from 2025 to 2035, culminating in a forecasted valuation of US$72.29 billion by the end of the period. This growth is driven by several key factors, including a rising number of regulatory approvals and product launches, the patent expiries of major biologics, and the increasing prevalence of chronic diseases that require effective and affordable treatment options.
- Published: June 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
